Systematic Evaluation of Studies in the Fields of Diagnosis and Management of Prostate Cancer in Coronavirus Disease 2019 Era
International Journal of Cancer Management
; 16(1) (no pagination), 2023.
Article
in English
| EMBASE | ID: covidwho-2312132
ABSTRACT
Background:
Prostate cancer is one of the most common cancers worldwide. The proper management of this cancer during the coronavirus disease 2019 (COVID-19) or similar outbreaks could be a serious challenge. Proper timing of surgery, radiotherapy, and other medical modalities are essential in providing the most effective treatment. Objective(s) This systematic review aimed at evaluating the proper management of prostate cancer during the COVID-19 outbreak. Method(s) This study was conducted from 2019 to 2022. An internet search was conducted using the keywords Diagnosis, man-agement, radical prostatectomy, radiotherapy, hormone ablation therapy, chemotherapy and prostate cancer, and COVID-19. The visited databases included PubMed, Scopus, Web of Sciences, Google Scholar, and Scientific Information Database. The review was performed based on the preferred reporting items for a systematic review and meta-analyses (PRISMA) guidelines. Result(s) Postponing the biopsy for up to three months and adopting of non-invasive diagnostic methods were likely reasonable during the COVID-19 pandemic. Patients with cancer were more prone to severe injuries and were more likely to have serious compli-cations. Surgery, radiation therapy, brachytherapy, palliative radiation, hormone ablation therapy, and chemotherapy were among the pre-institutional treatments that had to be performed according to medical protocols as well as health and professional guide-lines. Conclusion(s) It was recommended that the prostate cancer screening should not be performed for asymptomatic men during the COVID-19 outbreak. It was also suggested that the treatment should be performed in the shortest possible time and in the safest way.Copyright © 2023, Author(s).
Coronavirus Infection; Diagnosis; Pandemic; Prostate Cancer; adjuvant radiotherapy; androgen deprivation therapy; brachytherapy; cancer chemotherapy; cancer hormone therapy; cancer radiotherapy; cancer surgery; coronavirus disease 2019; digital rectal examination; histopathology; human; human tissue; male; meta analysis; morbidity; nuclear magnetic resonance imaging; prostate biopsy; prostate cancer/di [Diagnosis]; prostate cancer/dt [Drug Therapy]; prostate cancer/rt [Radiotherapy]; prostate imaging reporting and data system; prostatectomy; quality control; quality of life; review; systematic review; transrectal ultrasonography; urine incontinence; cefazolin/dt [Drug Therapy]; ciprofloxacin/dt [Drug Therapy]; prostate specific antigen/ec [Endogenous Compound]; quinoline derived antiinfective agent/dt [Drug Therapy]; quinolone/dt [Drug Therapy]; catheter
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Type of study:
Experimental Studies
/
Systematic review/Meta Analysis
Language:
English
Journal:
International Journal of Cancer Management
Year:
2023
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS